bpc-157 fda advisory committee recommends compounding peptides like and TB-500 The FDA cracked down on

Patients who are pregnant or breastfeeding, patients with active malignancy, patients with certain vascular conditions where angiogenesis is a concern, and patients on specific anticoagulants may not be candidates

A commercial category is not a scientific category Inclusion in a Peptides UK catalogue does not turn 5-Amino-1MQ into a peptide and does not establish that it is suitable for human administration

(January 1, 2007)

Consult Your Healthcare Provider If you experience excessive tiredness or nerve problems, your healthcare provider can do a blood test to check vitamin B12 levels and also rule out other potential causes for your symptoms